Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
12.30
+0.24 (1.99%)
Nov 18, 2026, 12:30 PM EST - Market open
Pharming Group Employees
Pharming Group had 407 employees as of December 31, 2025. The number of employees increased by 3 or 0.74% compared to the previous year.
Employees
407
Change (1Y)
3
Growth (1Y)
0.74%
Revenue / Employee
$950,243
Profits / Employee
$59,413
Market Cap
891.80M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 407 | 3 | 0.74% |
| Dec 31, 2024 | 404 | 22 | 5.76% |
| Dec 31, 2023 | 382 | 50 | 15.06% |
| Dec 31, 2022 | 332 | 55 | 19.86% |
| Dec 31, 2021 | 277 | 15 | 5.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 704 |
| MeiraGTx Holdings | 386 |
| Syndax Pharmaceuticals | 298 |
| Rigel Pharmaceuticals | 174 |
| Odyssey Therapeutics | 100 |
| Inventiva | 87 |
| Corvus Pharmaceuticals | 37 |
PHAR News
- 8 hours ago - Pharming Group Transcript: Jefferies Global Healthcare Conference - Transcripts
- 7 days ago - Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 12 days ago - MHRA Approves Pharming Group N.V.’s Joenja as First Treatment Specifically for Children with APDS in the U.K. - Nasdaq
- 12 days ago - MHRA approves Pharming's Joenja® (leniolisib) as first treatment specifically for children with APDS in the U.K. - GlobeNewsWire
- 14 days ago - Pharming Group Slides: Corporate presentation - Filings
- 20 days ago - Pharming price target raised to $41 from $38 at Canaccord - TheFly
- 22 days ago - Pharming (PHAR) Q3 2026 Earnings Call Transcript - The Motley Fool
- 22 days ago - Pharming Group Q3 Earnings Call Highlights - MarketBeat